Literature DB >> 18551883

The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits.

Angela M Wisniewski1, Christopher H Purdy, Richard D Blondell.   

Abstract

INTRODUCTION: Since the 1990s prescriptions for and the non-medical use of opioids have increased. This study examines associations between opioid prescribing, non-medical use, and emergency department (ED) visits.
METHODS: Data were abstracted from four federally sponsored, nationally representative, annual surveys (National Hospital Ambulatory Medical Care Survey, National Ambulatory Medical Care Survey, National Survey on Drug Use and Health, and Drug Abuse Warning Network).
RESULTS: For hydrocodone and oxycodone, associations between prescribing and non-medical use, and prescribing and ED visits were statistically significant (p-values < 0.04) and strongly associated (correlation coefficient range 0.73 to 0.87). Male gender, White race, and age > or = 35 were all statistically significant (p-values < 0.0001) predictors of receiving a hydrocodone or oxycodone-containing prescription.
CONCLUSION: The increased number of prescriptions written for hydrocodone and oxycodone between 1995 and 2004 was associated with similar increases in non-medical use and the number of ED visits during this time period.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18551883     DOI: 10.1300/J069v27n01_01

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  41 in total

1.  Prescription of opioids for opioid-naive medical inpatients.

Authors:  Sharan Lail; Kelly Sequeira; Jenny Lieu; Irfan A Dhalla
Journal:  Can J Hosp Pharm       Date:  2014-09

2.  Emergency department utilization and subsequent prescription drug overdose death.

Authors:  Joanne E Brady; Charles J DiMaggio; Katherine M Keyes; John J Doyle; Lynne D Richardson; Guohua Li
Journal:  Ann Epidemiol       Date:  2015-04-02       Impact factor: 3.797

3.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

4.  Effective Canadian policy to reduce harms from prescription opioids: learning from past failures.

Authors:  Benedikt Fischer; Jürgen Rehm; Mark Tyndall
Journal:  CMAJ       Date:  2016-11-07       Impact factor: 8.262

5.  Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009.

Authors:  Kevin D Shield; Wayne Jones; Jürgen Rehm; Benedikt Fischer
Journal:  Pain Res Manag       Date:  2013 Mar-Apr       Impact factor: 3.037

6.  Time trends in gastroparesis treatment.

Authors:  Anwar Dudekula; Shiraz Rahim; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2014-09-26       Impact factor: 3.199

7.  Race and Gender Are Associated with Opioid Dose Reduction Among Patients on Chronic Opioid Therapy.

Authors:  Michele Buonora; Hector R Perez; Moonseong Heo; Chinazo O Cunningham; Joanna L Starrels
Journal:  Pain Med       Date:  2019-08-01       Impact factor: 3.750

8.  Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005.

Authors:  Stephen M Thielke; Linda Simoni-Wastila; Mark J Edlund; Andrea DeVries; Bradley C Martin; Jennifer B Braden; Ming-Yu Fan; Mark D Sullivan
Journal:  Pain Med       Date:  2009-11-25       Impact factor: 3.750

Review 9.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

10.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.